DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery

Radiotherapy and Oncology

Volumn 93, Issue 2, 2009, Pages 316-321

  Haie Meder, Christine ^a   Chargari, Cyrus ^a,b   Rey, Annie ^a   Dumas, Isabelle ^a   Morice, Philippe ^a   Magné, Nicolas ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Hôpital d'Instruction des Armées du Val du Grâce   (France)

Author keywords

3D MRI based brachytherapy; Early stage cervical cancer; Preoperative brachytherapy

Indexed keywords

CISPLATIN;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; BLADDER DISEASE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DISEASE FREE SURVIVAL; EARLY CANCER; FEMALE; FOLLOW UP; HISTOGRAM; HUMAN; HYSTERECTOMY; LOW ENERGY RADIATION; LYMPH NODE DISSECTION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARAMETER; PELVIC FIBROSIS; PELVIS; PERIPHERAL NEUROPATHY; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; RECTUM DISEASE; SALPINGOOOPHORECTOMY; SMALL INTESTINE DISEASE; TREATMENT OUTCOME; URETER DISEASE; UTERINE CERVIX CANCER; VAGINA DISEASE;

ADULT; AGED; BRACHYTHERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 70350509592     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.05.004     Document Type: Article

References (33)

1. Haie-Meder C., Morice P., and Castiglione M. On behalf of the ESMO Guidelines Working Group. Cervical cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19 (2008) 17-18
2. Mundt A.J., Waggoner S., Herbst A., and Rotmensch J. Preoperative intracavitary brachytherapy in early-stage cervical carcinoma. Am J Clin Oncol 22 (1999) 73-77
3. Gerbaulet A., Kunkler I.H., Kerr G.R., et al. Combined radiotherapy and surgery: local control and complications in early carcinoma of the uterine cervix-the Villejuif experience, 1975-1984. Radiother Oncol 23 (1992) 66-73
4. Resbeut M.R., Alzieu C., Gonzague-Casabianca L., et al. Combined brachytherapy and surgery for early carcinoma of the uterine cervix: analysis of extent of surgery on outcome. Int J Radiat Oncol Biol Phys 50 (2001) 873-881
5. Calais G., Le Floch O., Chauvet B., et al. Carcinoma of the uterine cervix stage IB and early IIB. Prognostic value of the histological tumor regression after initial brachytherapy. Int J Radiat Oncol Biol Phys 17 (1989) 1231-1235
6. Pilleron J.P., Durand J.C., Hamelin J.M., et al. Traitement radiochirurgical du cancer du col de l'utérus au stade I. Limites de l'évidement ganglionnaire et résultats. A propos de 366 cas traités a' la Fondation Curie et suivis depuis plus de 5 ans. Chirurgie 99 (1973) 687-692
7. Potter R., Kirisits C., Fidarova E.F., Dimopoulos J.C., Berger D., Tanderup K., et al. Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma. Acta Oncol (2008) 1-12
8. Haie-Meder C., Pötter R., Van Limbergen E., et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 74 (2005) 235-245
9. Chajon E., Dumas I., Touleimat M., et al. Inverse planning approach for 3-D MRI-based pulse-dose rate intracavitary brachytherapy in cervix cancer. Int J Radiat Oncol Biol Phys 69 (2007) 955-961
10. International Commission on Radiation Units and Measurements. ICRU report 38: dose and volume specification for reporting intracavitary therapy in gynaecology. Bethesda, MD: ICRU; 1985.
11. Haie-Meder C. GYNE GEC ESTRO working group (I). 3D image based concepts in brachytherapy for cervical cancer. Gynecol Oncol 99 (2005) 176
12. Pötter R., Haie-Meder C., Van Limbergen E., et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 78 (2006) 67-77
13. Dale R.G. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol 58 (1985) 515-528
14. Dale R.G. The application of the linear-quadratic model to fractionated radiotherapy when there is incomplete normal tissue recovery between fractions and possible implications for treatments involving multiple fractions per day. Br J Radiol 59 (1986) 919-927
15. Creasman W.T., Soper J.T., and Clarke-Pearson D. Radical hysterectomy as therapy for early carcinoma of the cervix. Am J Obstet Gynecol 155 (1986) 964-969
16. Barillot I., Horiot J.C., Pigneux J., et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study. Update and multivariate analysis of prognostic factors. Int J Radiat Oncol Biol Phys 38 (1997) 969-978
17. Perez C.A., Grigsby P.W., Camel M.H., et al. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: update of a non randomized comparison. Int J Radiat Oncol Biol Phys 31 (1995) 703-716
18. Thoms W.W., Eifel P.J., Smith T.L., et al. Bulky endocervical carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys 23 (1992) 491-499
19. Atlan D., Touboul E., Deniaud-Alexandre E., et al. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 54 (2002) 780-793
20. Landoni F., Maneo A., Colombo A., et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350 (1997) 535-540
21. Newton M. Radical hysterectomy or radiotherapy for stage I cervical cancer. A prospective comparison with 5 and 10 years follow-up. Am J Obstet Gynecol 123 (1975) 535-542
22. Perez C.A., Camel H.M., Kao M.S., et al. Randomized study of preoperative radiation and surgery or irradiation alone in the treatment of stage IB and IIA carcinoma of the uterine cervix: final report. Gynecol Oncol 27 (1987) 129-140
23. Morley G.W., and Seski J.C. Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix (exclusive of microinvasion). Am J Obstet Gynecol 126 (1976) 785-798
24. Roddick Jr. J.W., and Greenelaw R.H. Treatment of cervical cancer. A randomized study of operation and radiation. Am J Obstet Gynecol 109 (1971) 754-764
25. Cai H.B., Chen H.Z., Zhou Y.F., Lie D.M., and Hou H.Y. Class II radical hysterectomy in low-risk IB squamous cell carcinoma of cervix: a safe and effective option. Int J Gynecol Cancer 19 (2009) 46-49
26. Pötter C., Kirisits R., Lang S., et al. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62 (2005) 901-911
27. De Brabandere M., Mousa A.G., Nulens A., Swinnen A., and Van Limbergen E. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol 88 (2008) 217-226
28. Lindegaard J.C., Tanderup K., Nielsen S.K., Haack S., and Gelineck J. MRI-guided optimization significantly improves DVH parameters of pulsed-dose rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 71 (2008) 756-764
29. Pötter R., Dimopoulos J., Georg P., et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 83 (2007) 148-155
30. Charvolin J.Y., Nos C., Rochefordière Ade L., Margerie V.J., Durand J.C., and Clough K.B. Relevance of combined radiation and surgical treatment of early invasive carcinoma of the cervix. Bull Cancer 88 (2001) 1207-1212
31. Chargari C., Magné N., Dumas I., et al. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys 74 (2009) 133-139
32. Haie-Meder C., Kramar A., Lambin P., et al. Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma. Int J Radiat Oncol Biol Phys 29 (1994) 953-960
33. Perez C.A., Grigsby P.W., Chao K.S., Mutch D.G., and Lockett M.A. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys 41 (1998) 307-317